[HTML][HTML] Adjunctive viral cell culture supports treatment decision‐making in patients with secondary humoral immunodeficiency and persistent SARS‐CoV‐2 infection
SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Discussion Determining SARS-CoV-2 viability in patients with haematological malignancy
has implications for treatment-based decision-making. For example, B-cell depletion with …
has implications for treatment-based decision-making. For example, B-cell depletion with …
[引用][C] Adjunctive viral cell culture supports treatment decision‐making in patients with secondary humoral immunodeficiency and persistent SARS‐CoV‐2 infection
SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2022 - Wiley Online Library
Discussion Determining SARS-CoV-2 viability in patients with haematological malignancy
has implications for treatment-based decision-making. For example, B-cell depletion with …
has implications for treatment-based decision-making. For example, B-cell depletion with …
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection
SJC Pallett, R Wake, J Youngs… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Adjunctive viral cell culture supports treatment decision-making in patients with secondary
humoral immunodeficiency and persistent SARS-CoV-2 infection Adjunctive viral cell culture …
humoral immunodeficiency and persistent SARS-CoV-2 infection Adjunctive viral cell culture …
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection
SJC Pallett, R Wake, J Youngs… - British Journal of …, 2022 - openaccess.sgul.ac.uk
Persistent Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) infection is 73
observed among patients with haematological malignancy, conferring an increased mortality …
observed among patients with haematological malignancy, conferring an increased mortality …
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection.
SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2021 - europepmc.org
Discussion Determining SARS-CoV-2 viability in patients with haematological malignancy
has implications for treatment-based decision-making. For example, B-cell depletion with …
has implications for treatment-based decision-making. For example, B-cell depletion with …
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection.
SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2021 - europepmc.org
Persistent Severe Acute Respiratory Syndrome coronavirus‐2 (SARS‐CoV‐2) infection is
observed among patients with haematological malignancy, conferring an increased mortality …
observed among patients with haematological malignancy, conferring an increased mortality …
[PDF][PDF] Adjunctive viral cell culture supports treatment decision making in patients with 1 secondary humoral immunodeficiency and persistent SARS-CoV-2 infection 2
SJC Pallett, R Wake, J Youngs, C Pope, NK Tan… - openaccess.sgul.ac.uk
Persistent Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) infection is 73
observed among patients with haematological malignancy, conferring an increased mortality …
observed among patients with haematological malignancy, conferring an increased mortality …